Cargando…
BRCA2 mutation carriers, reproductive factors and breast cancer risk
BACKGROUND: Germline mutations in the BRCA genes dramatically increase the risk of breast cancer. In the general population, breast cancer risk is affected by age at menarche, by age at first birth, by the number of births and by the duration of breast feeding. Whether this is true for mutation carr...
Autores principales: | Tryggvadottir, Laufey, Olafsdottir, Elinborg J, Gudlaugsdottir, Sigfridur, Thorlacius, Steinunn, Jonasson, Jon G, Tulinius, Hrafn, Eyfjord, Jorunn E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC314423/ https://www.ncbi.nlm.nih.gov/pubmed/12927042 |
Ejemplares similares
-
Estrogen receptor-positive breast cancer and adverse outcome in BRCA2 mutation carriers and young non-carrier patients
por: Vidarsdottir, Linda, et al.
Publicado: (2023) -
Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers
por: Jonasson, Jon G, et al.
Publicado: (2016) -
Aurora A is a prognostic marker for breast cancer arising in BRCA2 mutation carriers
por: Aradottir, Margret, et al.
Publicado: (2014) -
BRCA1 Promoter Methylation Status in 1031 Primary Breast Cancers Predicts Favorable Outcomes Following Chemotherapy
por: Stefansson, Olafur A, et al.
Publicado: (2019) -
A DNA methylation‐based definition of biologically distinct breast cancer subtypes
por: Stefansson, Olafur A., et al.
Publicado: (2014)